Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
The above findings underscore the potential of GLP-1R agonists as efficacious and safe drugs with pleiotropic activities on cardiovascular system that are independent of their glycemic control effects emphasizing cardiovascular outcomes as one of the primary goals in the management of type 2 diabetes
We need to bridge nutritional and pharmacological research for long-term successful implementation of weight loss medication in practice
With the availability of multiple drug therapies demonstrating promising efficacy, we expect market competition to produce downward pressure on prices, most likely in the form of rebates for GLP-1s
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
